title: Adverse experiences in an Exosurf treated group.
authors.forename: S L
authors.initials: SL
authors.lastname: Chatfield
authors.forename: E J
authors.initials: EJ
authors.lastname: Kelly
authors.forename: P R
authors.initials: PR
authors.lastname: Dear
mesh_terms: D016022:Case-Control Studies; D004338:Drug Combinations; D005233:Fatty Alcohols / Q000009:adverse effects*; D006801:Humans; D006819:Hyaline Membrane Disease / Q000188:drug therapy; D007231:Infant, Newborn; D007234:Infant, Premature; D010767:Phosphorylcholine; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011663:Pulmonary Surfactants / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D004338:Drug Combinations; D005233:Fatty Alcohols; D011663:Pulmonary Surfactants; D010767:Phosphorylcholine; D011092:Polyethylene Glycols; C047049:dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination